Skip to main content

United Community Banks, Inc. and 21st Mortgage Corporation Close Sale of Manufactured Housing Loan Portfolio

GREENVILLE, S.C., Sept. 03, 2024 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (“United”) announced today the August 30th closing of the sale of substantially all of its manufactured housing loan portfolio, totaling $318.2 million, to 21st Mortgage Corporation, a division of Clayton Homes. The business was part of the Reliant Bancorp, Inc. acquisition in January of 2022. The portfolio had been in runoff following United’s decision to cease originations in the third quarter of 2023. “Rather than continue to slowly liquidate the portfolio through normal collections, we took this opportunity to accelerate our exit from this business,” said Lynn Harton, Chairman and CEO. “21st Mortgage Corporation is the premier lender in this area with great capability to service the customers. In addition to removing a management distraction,...

Continue reading

Weatherford Announces Acquisition of Datagration

HOUSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) — Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced the acquisition of Datagration Solutions Inc., an innovator in unified data integration, analytics, and machine learning. The acquisition establishes Weatherford as having one of the industry’s most capable and contemporary digital offerings for production and asset optimization and demonstrates its commitment to continuously driving innovation across its technology portfolio. The integration of Weatherford’s digital offering with Datagration’s unified data models creates a powerful solution for surveillance, optimization, and decision-making across the well lifecycle. The combination enhances Weatherford’s capabilities in digital transformation and drives amplified synergies with its ForeSite®,...

Continue reading

Form 8.3 – AXA INVESTMENT MANAGERS: Rightmove Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Rightmove plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

SPAR Group Enters into Definitive Agreement to be Acquired by Highwire Capital for $2.50 Per Share

Letter of Intent Previously Announced on June 5, 2024 $2.50 Per Share Merger Consideration Represents a 72% Premium to SPAR Group’s Closing Share Price on August 30AUBURN HILLS, Mich., Sept. 03, 2024 (GLOBE NEWSWIRE) — SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR”, “SPAR Group” or the “Company”), a provider of merchandising, marketing and distribution services, announced today it has entered into a definitive agreement to be acquired by Highwire Capital (“Highwire”), an investment firm focused on transforming businesses through technology. Under the terms of the agreement, which has been unanimously approved by SPAR Group’s Board of Directors, SPAR Group stockholders will receive $2.50 per share in cash, representing a 72% premium over the closing share price on the last trading day before the announcement and a 37.8%...

Continue reading

PharmaCorp Completes Acquisition of a Pharmacy in Western Canada

SASKATOON, Saskatchewan, Sept. 03, 2024 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that, further to its news release dated August 22, 2024, it has completed the acquisition of a 90% interest in a pharmacy (the “Acquired Pharmacy”) located in Western Canada. The acquisition of the Acquired Pharmacy is an arm’s length transaction. The aggregate purchase price for the 90% interest in the Acquired Pharmacy was $2,207,170 and was funded from cash. The Acquired Pharmacy represents PharmaCorp’s second acquisition following the successful completion of its Qualifying Transaction on June 6, 2024, which included the acquisition of a 75% interest in a pharmacy in Saskatoon, Saskatchewan, as well as the previously announced strategic alliance with PharmaChoice Canada Inc. “We...

Continue reading

Invesco Ltd: Form 8.3 – REA Group Ltd; Opening Position Disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree REA Group Ltd  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Continue reading

Colliers to acquire leading Western Australian engineering firm

Acquisition expands geographic presence, scale and service capabilitiesTORONTO AND PERTH, Sept. 03, 2024 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: CIGI), announced today that Colliers Engineering & Design Australia (“Colliers Engineering”) has entered into a definitive agreement to acquire Pritchard Francis Consulting Pty Limited (“Pritchard Francis”), one of Western Australia’s leading multi-discipline engineering consulting firms. Pritchard Francis’ senior leadership team will continue to lead the business in Western Australia and become significant shareholders in the Colliers Engineering platform under the unique Colliers partnership model. The business will rebrand as “Colliers Engineering & Design” and fully integrate into Colliers’ rapidly...

Continue reading

Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million

Oruka is advancing a pipeline of potentially best-in-class biologics that aim to offer greater freedom from disease to people with plaque psoriasis and other associated conditions Company on track to advance co-lead programs, ORKA-001 and ORKA-002, into the clinic and show initial pharmacokinetic data for ORKA-001 next year Samarth Kulkarni, PhD, appointed Chairman of Oruka’s Board of Directors Shares to trade on Nasdaq under the ticker symbol “ORKA” commencing today, September 3, 2024 MENLO PARK, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, today announced the completion of its previously announced merger with ARCA biopharma, Inc....

Continue reading

Invesco Ltd: Form 8.3 -Rightmove PLC; Opening Position Disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Rightmove PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Continue reading

The Ensign Group Adds Seven New Operations in Colorado

SAN JUAN CAPISTRANO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of the following skilled nursing facilities in Colorado:Desert Willow Health and Rehabilitation Center, a 106-bed skilled nursing facility located in Pueblo, Colorado; Junction Creek Health and Rehabilitation Center, a 133-bed skilled nursing facility located in Durango, Colorado; Pelican Pointe Health and Rehabilitation Center, a 104-bed skilled nursing facility located in Windsor, Colorado; Riverbend Health and Rehabilitation Center, a 100-bed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.